What’s ahead for Eli Lilly and Novo as RFK Jr. takes over HHS
Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock face investor scrutiny as RFK Jr. takes the leadership of HHS. Read more ...
Natco Pharma: Looming gap in earnings
Natco Pharma stock corrected sharply due to weak Q3 results, but future opportunities like semaglutide offer hope.
pharmaphorum22h
Novo Nordisk splashes out as oral semaglutide starts phase III
Novo Nordisk's semaglutide, which could be the first oral ... with a low risk of low blood sugar and beneficial effects on weight and appetite. The new oral formulation has been developed with ...
The Lancet22h
Effects of semaglutide on heart failure outcomes
aCardiovascular R&D Centre – UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto 4200-319, Portugal ...